Covered recipient · General Payments record
LAURA IRASTORZA
Allopathic & Osteopathic Physicians Pediatrics Pediatric Gastroenterology
General Payments · PY2018–2024
$3,171.45
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,156.00 | 1 |
| Food and Beverage | $558.56 | 7 |
| Travel and Lodging | $302.39 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $1,431.69 | 6 |
| EvoEndo, Inc | $302.39 | 1 |
| Ipsen Biopharmaceuticals, Inc | $150.00 | 1 |
| Regeneron Healthcare Solutions, Inc. | $132.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| EvoEndo, Inc | $302.39 | 10/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1067616012 | CMS |
| GENZYME CORPORATION | $41.46 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139927493 | CMS |
| GENZYME CORPORATION | $1,156.00 | 03/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139927495 | CMS |
| GENZYME CORPORATION | $66.13 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139927485 | CMS |
| GENZYME CORPORATION | $65.22 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139927551 | CMS |
| GENZYME CORPORATION | $76.85 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139927559 | CMS |
| GENZYME CORPORATION | $26.03 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139927561 | CMS |
| Ipsen Biopharmaceuticals, Inc | $150.00 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091992335 | CMS |
| Regeneron Healthcare Solutions, Inc. | $132.87 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114074853 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.